Social Evaluated Cold Pressor Test in Hereditary Angioedema Patients
NCT ID: NCT06414252
Last Updated: 2024-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2023-05-15
2024-03-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Burden of Illness and Treatment Patterns in Teenagers and Adults With Hereditary Angioedema
NCT04957641
Validation of the MoistureMeterD in Local Edema by Histamine
NCT01833156
Angioedema Biomarker Research Study
NCT06210698
A Call Center During HAE Attacks (SOS HAE)
NCT01679912
HAE Burden and Crisis Management
NCT06806618
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with hereditary angioedema
Patients with documented diagnosis of hereditary angioedema due to C1 inhibitor deficiency and aged between 18 and 65 years.
No interventions assigned to this group
Healthy individuals
Healthy individuals with an age between 18 and 65 and matched with patients with hereditary angioedema by age and gender.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Active acute disease;
* Sars-Cov2 infection in the previous 3 months.
* An acute attack experienced within the previous week and within 72 hours after the registration (a posteriori exclusion).
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituti Clinici Scientifici Maugeri SpA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituti Clinici Scientifici Maugeri
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2774CE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.